Overweight clinical trials
The registry lists 3,599 studies for Overweight across more than 10 countries. 852 are recruiting or about to start. 449 of them are mainly about Overweight (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 8 narrower conditions too, such as Obesity: 13,892 studies, 2,412 open.
ClinicalTrials.gov finds 14,281 studies for Overweight. How that becomes 3,592 here
This page counts the studies the registry files under Overweight, and those it files under no condition that list Overweightthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count
- 14,281Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −10,157Filed under a narrower condition, counted on its own pageObesity 8,336 · Pediatric Obesity 760 · Obesity, Morbid 667 · Obesity, Abdominal 170 · Prader-Willi Syndrome 110 · Obesity Hypoventilation Syndrome 61 · 2 more
- −11List Overweight as a condition, but the registry did not file them under itMost often written as “Overweight Adolescents” (4), “Overweight and/or Obesity” (4), and “Body Weight in the Overweight and Obese Class - I Population” (3). The registry filed them under other conditions only, most often Body Weight (3) and Motor Activity (2).
- −521Match it another way511 name it in the title, 8 in a keyword, and 2 by a synonym or other text the search reads.
- 3,592The count on this page32 of them list Overweight in their own words; the registry filed them under no condition.
Get an email when these change. Save the Overweight studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Novo Nordisk A/S (99) · Eli Lilly and Company (93) · Maastricht University Medical Center (41) · University of California, San Diego (33) · University of North Carolina, Chapel Hill (32) · University of Colorado, Denver (30) · Pfizer (30) · Massachusetts General Hospital (27)
What is being tested here
Drugs under test in Overweight studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Tirzepatide | 28 | 17 | 51 |
| Semaglutide | 24 | 21 | 52 |
| Eloralintide | 13 | 7 | 20 |
| Zenagamtide | 12 | 9 | 17 |
| Berobenatide | 10 | 11 | 19 |
| Maridebart cafraglutide | 8 | 10 | 25 |
| Mazdutide | 6 | 2 | 11 |
| Cagrilintide | 5 | 8 | 19 |
| Enicepatide | 5 | 4 | 7 |
| UBT251 | 5 | 1 | 6 |
Drug classes tested here GLP-1 receptor agonists 58 open · SGLT2 inhibitors 2 open · Statins 2 open · Angiotensin receptor blockers (ARBs) 1 open · Serotonin receptor agonists 9
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Nov 2026A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight · Phase 3 · Eli Lilly and Company
- Nov 2026A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight · Phase 3 · Eli Lilly and Company
- Dec 2026The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED) · Phase 3 · University of Virginia
- Dec 2026A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) · Phase 3 · Innovent Biologics (Suzhou) Co. Ltd.
- Dec 2026Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus · Phase 3 · HK inno.N Corporation
- Jan 2027Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight · Phase 3 · Amgen
- Jan 2027Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight · Phase 3 · Amgen
- Feb 2027A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) · Phase 3 · Eli Lilly and Company
- Feb 2027Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1) · Phase 3 · Hudson Biotech
- Apr 2027Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease · Phase 3 · Amgen
Who these studies take
Of the 529 Overweight studies recruiting now, 158 (30%) set no upper age limit and 343 (65%) stop at 75 or younger. 62 (12%) take children under 18. 50 (9%) are for women only and 9 (2%) for men only; 204 (39%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 33 (6%) | 31 (6%) |
| 18 | 400 (76%) | 373 (71%) |
| 30 | 435 (82%) | 406 (77%) |
| 40 | 442 (84%) | 410 (78%) |
| 50 | 424 (80%) | 399 (75%) |
| 65 | 345 (65%) | 334 (63%) |
| 75 | 231 (44%) | 223 (42%) |
| 85 | 166 (31%) | 158 (30%) |
Across all 3,599 studies, recruiting or not: 72% stop at 75 or younger and 57% at 65; 15% take children; 13% are for women only and 4% for men only; 50% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Overweight studies take
Of 230 phase 1 interventional studies under Overweight, half reached primary completion within 9 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 9 mo5–16 · 230 studies | 8 mo5–14 · 211 studies | — |
| Phase 1/2 | 15 mo12–34 · 24 studies | — | — |
| Phase 2 | 13 mo8–21 · 148 studies | 12 mo8–16 · 102 studies | 35 mo12–69 · 46 studies |
| Phase 2/3 | 47 mo31–59 · 12 studies | — | — |
| Phase 3 | 21 mo18–28 · 136 studies | 21 mo18–27 · 127 studies | — |
| Phase 4 | 25 mo13–42 · 48 studies | — | — |
| Interventional, no phase | 17 mo8–38 · 1,411 studies | 11 mo6–25 · 111 studies | 18 mo8–38 · 1,300 studies |
| Observational | 37 mo15–91 · 169 studies | — | 43 mo17–121 · 152 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting31
- A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in People With Reduced Liver Function and Normal Liver FunctionNov 10, 2026NCT07587710
- Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or ObesityNov 10, 2026NCT07830329
- Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or OverweightNov 9, 2026NCT07871409
- A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)Nov 6, 2026NCT07794774
- A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or ObesityNov 6, 2026NCT07874633
Show 26 moreShow fewer
- A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or ObesityNov 6, 2026NCT07876531
- Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 DiabetesNov 5, 2026NCT07866066
- Study of UBT37034 InjectionNov 5, 2026NCT07873645
- Confident Moves Intervention Efficacy Trial: Obesity Care SettingsNov 4, 2026NCT07623772
- Body-Based and Mind-Based Regulation in Overweight and Obese WomenNov 4, 2026NCT07738263
- Dance-Based Exercise Versus Clinical Pilates in Women With Overweight or ObesityNov 4, 2026NCT07745166
- A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 DiabetesNov 4, 2026NCT07881458
- SHIFT-TB: Nutrition Intervention and EvaluationNov 3, 2026NCT07836322
- Safety and Analgesic Efficacy of the Biased μ-Opioid Receptor Agonist Tegileridine for Post-Operative Analgesia in Patients Undergoing Bariatric SurgeryNov 3, 2026NCT07844512
- Effects of Concurrent Training on Serum PCSK9 Levels in Adults With OverweightNov 3, 2026NCT07910916
- FutureShape FamilyOct 29, 2026NCT07872904
- AI-Driven Metabolic Cohort in Overweight/Obese Chinese AdultsOct 27, 2026NCT07584330
- Translational Health Research Into Vascular and Neurocognitive Effects of Weight LossOct 26, 2026NCT07592546
- A Study of SA030 Injection in Overweight or Obese ParticipantsOct 23, 2026NCT07479862
- A Single Ascending Dose and Multiple Ascending Doses Study of SYH2082 Injection in Healthy ParticipantsOct 23, 2026NCT07532655
- Multimodal Intervention for Weight Management and Health in the Elderly PopulationOct 20, 2026NCT07820774
- PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility StudyOct 20, 2026NCT07874828
- A Study of IBI3046 in Participants With Overweight or ObesityOct 19, 2026NCT07809945
- A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle InterventionOct 16, 2026NCT07798284
- A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide MedicationOct 16, 2026NCT07855133
- A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide MedicationOct 16, 2026NCT07868354
- A Study to Evaluate Efficacy and Safety of BGM0504 Tablets in Overweight or Obese Participants Without DiabetesOct 15, 2026NCT07658560
- A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or ObesityOct 15, 2026NCT07792954
- A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)Oct 15, 2026NCT07794761
- A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or ObesityOct 15, 2026NCT07845500
- Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or ObesityOct 13, 2026NCT07657676
Results posted4
- A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesNov 9, 2026NCT05936151
- The Feasibility and Preliminary Efficacy of the Mindful-Healthy Family Intervention With Rural FamiliesNov 6, 2026NCT05324969
- Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health InterventionNov 4, 2026NCT05249465
- A Study of CT-868 in Type 1 Diabetes MellitusOct 28, 2026NCT06062069
Stopped4
- The Impact of Continuous Glucose Monitoring on Glucose Variability and Weight Loss in Individuals With Prediabetes and ObesitySuspendedNov 4, 2026NCT07423065
- Physical Exercise Prehabilitation Program in mEtabolic suRgeryTerminatedOct 30, 2026NCT06889207
- GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial EmulationWithdrawnOct 16, 2026NCT07677865
- A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related ComorbiditiesTerminatedOct 13, 2026NCT07553299
Newly registered68
- Effects of Thai Food-Specific Inhibition Control Training on Psychophysiological Outcomes in Thai Adults With ObesityNov 10, 2026NCT07928817
- A Study to Evaluate the Safety and Efficacy of Ecnoglutide Tablets in Chinese Participants With Overweight or ObesityNov 10, 2026NCT07929298
- The Impact of Incretins on Fat-free Mass, Muscle Strength and Functional CapacityNov 10, 2026NCT07929831
- A Single Ascending Dose and Multiple Ascending Dose Trial to Assess the Dose, the Efficacy and Oro-sensitivity of Two Modified Linoleic Acids NKS-3 and NKS-5Nov 9, 2026NCT07924267
- A Study to Investigate the Effect of Injection Site and Ethnicity on KAI-4729 Pharmacokinetics in Non-Asian and Asian Participants Living With Obesity or OverweightNov 9, 2026NCT07924761
Show 45 moreShow fewer
- Determination of ED90 of Remimazolam Besylate Combined With Alfentanil for Gastroscopy Sedation in Obese PatientsNov 9, 2026NCT07925684
- Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 DiabetesNov 9, 2026NCT07926152
- Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous Presentations After Multiple DosesNov 6, 2026NCT07921316
- Effect of Probiotics on Insulin Sensitivity in Overweight and Obese PregnancyNov 6, 2026NCT07921940
- Lifestyle Interventions and Genetic Scores for Weight ManagementNov 6, 2026NCT07922005
- A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 DiabetesNov 6, 2026NCT07922330
- A Phase I Clinical Trial of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of UBT48128 Tablets in Healthy ParticipantsNov 6, 2026NCT07922798
- Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic DisordersNov 6, 2026NCT07923240
- A Study to Evaluate Efficacy and Safety of BGM1812 Injection in Overweight or Obese Participants Without DiabetesNov 5, 2026NCT07918625
- A Clinical Study Testing Enicepatide in Participants Living With Overweight or Obesity and Cardiovascular DiseaseNov 5, 2026NCT07918846
- Impact of Dyslipidemia on Metabolic Health of Adults With Overweight/Obesity (IDOM): A Study at the San Raffaele Hospital Center for Metabolic HealthNov 5, 2026NCT07919158
- A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)Nov 5, 2026NCT07919678
- A Study of LY4247147 in Participants With Obesity or Overweight Who Are Otherwise HealthyNov 4, 2026NCT07915245
- A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)Nov 4, 2026NCT07915609
- A Study of Zovaglutide (ZT002 Injection) in Participants With Hepatic Impairment and Healthy ParticipantsNov 4, 2026NCT07916194
- The Effect of Liraglutide on Body Weight, Body Composition, Ectopic Lipid Accumulation and Insulin Sensitivity in Subjects With Overweight or Obesity Without DiabetesNov 3, 2026NCT07913685
- Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)Nov 2, 2026NCT07908316
- ERCG vs Intensive Lifestyle Intervention for Weight Regain After GLP-1 RA DiscontinuationNov 2, 2026NCT07908823
- An Open Label Pilot Study Assessing the Impact of Chromium Picolinate Supplementation on Appetite and Cravings in Overweight IndividualsNov 2, 2026NCT07909109
- Effects of a Multispecies Probiotic on Metabolic, Liver, and Gut HealthNov 2, 2026NCT07909772
- Effects of Concurrent Training on Serum PCSK9 Levels in Adults With OverweightNov 2, 2026NCT07910916
- A Trial to Assess the Relative Bioavailability of Different Subcutaneous Formulations of AZD9550 and AZD6234Nov 2, 2026NCT07911514
- Transcutaneous Auricular Vagus Nerve Stimulation Combined With Lifestyle Intervention for Visceral Fat Reduction in Adults With Overweight or ObesityOct 30, 2026NCT07907029
- Oxytocin for Respiratory Compromise and Hypoventilation Induced by DrugsOct 29, 2026NCT07902752
- Sustaining Health After an Intensive Weight-loss Pro-grammeOct 28, 2026NCT07900178
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskOct 28, 2026NCT07900633
- Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With ObesityOct 28, 2026NCT07901777
- Mazdutide for Reducing Atrial Fibrillation Recurrence After Catheter Ablation in Obese PatientsOct 27, 2026NCT07897305
- Investigating the Effects of 24 Hour LEAP2 Infusion in Individuals With Overweight and ObesityOct 27, 2026NCT07897383
- Impact of Significant Surgical Reduction of Adipose Tissue on Plasma Levels and Genetic Expression of Adipokines Associated With Ischemic Heart Disease in Type I Obesity.Oct 27, 2026NCT07897682
- Testing Health-Related Interventions: Voices of Equity Needed to Overcome Weight-bias in Obesity-Cancer CareOct 27, 2026NCT07897890
- Gut Microbiota-Based Clinical Study of Akkermansia Supplementation for Overweight and ObesityOct 27, 2026NCT07898267
- Motivational Interviewing Intervention for Families With Overweight and ObesityOct 26, 2026NCT07893717
- Changes in Intestinal Permeability and Systemic Inflammation Following Fast Food Overfeeding.Oct 26, 2026NCT07893743
- A Study to Evaluate the Effects of a Dietary Supplement on Weight Management and Appetite ControlOct 26, 2026NCT07895563
- Efficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without DiabetesOct 26, 2026NCT07896265
- Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.Oct 23, 2026NCT07891156
- Individual Variability in Energy Compensation After a 12-Week Supervised Exercise InterventionOct 23, 2026NCT07893249
- A Controlled Study to Evaluate the Effects of a Supplement on Weight Loss, Blood Sugar, and Appetite SuppressionOct 22, 2026NCT07889570
- A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 DiabetesOct 22, 2026NCT07890376
- A Study to Evaluate a Single Dose of IBIO-610 in Participant With Obesity.Oct 22, 2026NCT07890870
- Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity RisksOct 21, 2026NCT07884903
- Study of Grape Consumption in Adaptation to Seasonal PhotoperiodOct 21, 2026NCT07886788
- A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 DiabetesOct 20, 2026NCT07881887
- A PHASE 2A, EXPLORATORY, RANDOMIZED, SINGLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY OF WEIGHT LOSS INDUCED BY NKS-3 IN OBESE ADULTS.Oct 20, 2026NCT07882654
and 18 more not listed
Studies
Recruiting first, then most recently updated. Showing 50 of 3,599. Browse all 3,599 → or search them.
- A Study to Evaluate the Safety and Efficacy of Ecnoglutide Tablets in Chinese Participants With Overweight or ObesityNot yet recruitingNCT07929298Phase 21 country
- Effects of Thai Food-Specific Inhibition Control Training on Psychophysiological Outcomes in Thai Adults With ObesityEnrolling by invitationNCT07928817Not applicable1 country
- The Impact of Incretins on Fat-free Mass, Muscle Strength and Functional CapacityRecruitingNCT079298311 country
- Time Restricted Eating (TRE) in Bipolar DisorderRecruitingNCT07211217Not applicable1 country
- Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or ObesityRecruitingNCT07830329Phase 21 country
- A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in People With Reduced Liver Function and Normal Liver FunctionRecruitingNCT07587710Phase 11 country
- Testing Just-in-Time Adaptive Interventions (JITAIs) to Prevent Goal Disengagement in Response to Weight RegainRecruitingNCT07708064Not applicable1 country
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 DiabetesRecruitingNCT07351058Phase 322 countries
- Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)RecruitingNCT03407079Phase 21 country
- A 12-week Field Trial of the Movámonos Physical Activity Support ProgramNot yet recruitingNCT07561996Not applicable
- A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes MellitusRecruitingNCT07775404Phase 35 countries
- Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or OverweightRecruitingNCT07871409Phase 32 countries
- A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusRecruitingNCT07776509Phase 311 countries
- Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 DiabetesNot yet recruitingNCT07926152Not applicable1 country
- Determination of ED90 of Remimazolam Besylate Combined With Alfentanil for Gastroscopy Sedation in Obese PatientsRecruitingNCT07925684Not applicable1 country
- Probiotics, Cognition and Metabolic Health in Young Adults With Overweight or ObesityRecruitingNCT07073781Not applicable1 country
- A Study to Investigate the Effect of Injection Site and Ethnicity on KAI-4729 Pharmacokinetics in Non-Asian and Asian Participants Living With Obesity or OverweightNot yet recruitingNCT07924761Phase 11 country
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 DiabetesRecruitingNCT07351045Phase 321 countries
- Metabolic Health, Bones and Nuts During Weight Loss in AdultsRecruitingNCT06949280Not applicable1 country
- A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)RecruitingNCT07794774Phase 31 country
- A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or ObesityRecruitingNCT07874633Phase 31 country
- Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous Presentations After Multiple DosesNot yet recruitingNCT07921316Phase 1
- A Phase I Clinical Trial of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of UBT48128 Tablets in Healthy ParticipantsNot yet recruitingNCT07922798Phase 11 country
- A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 DiabetesNot yet recruitingNCT07922330Phase 32 countries
- Effectiveness of a 10-week Multicomponent Intervention Combined With Parent Education on Binge Eating Behavior in Children and AdolescentsNot yet recruitingNCT07301541Not applicable1 country
- A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or ObesityRecruitingNCT07876531Phase 11 country
- Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With ObesityRecruitingNCT079017771 country
- Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without DiabetesRecruitingNCT07685808Phase 21 country
- Exercise Training and Vitamin D MetabolismRecruitingNCT07300332Not applicable1 country
- Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)RecruitingNCT07575399Phase 32 countries
- A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)RecruitingNCT07794761Phase 31 country
- A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 DiabetesRecruitingNCT07843485Phase 31 country
- A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)RecruitingNCT07823608Phase 31 country
- A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or ObesityRecruitingNCT07792954Phase 31 country
- A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 ObesityRecruitingNCT07794579Phase 312 countries
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or ObesityRecruitingNCT07595549Phase 311 countries
- A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 DiabetesRecruitingNCT07670416Phase 31 country
- A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or ObesityRecruitingNCT07845500Phase 32 countries
- Truway Diagnostic Tools in Primary CareEnrolling by invitationNCT07209527Early Phase 11 country
- A Clinical Study Testing Enicepatide in Participants Living With Overweight or Obesity and Cardiovascular DiseaseNot yet recruitingNCT07918846Phase 3
- A Study to Evaluate Efficacy and Safety of BGM1812 Injection in Overweight or Obese Participants Without DiabetesNot yet recruitingNCT07918625Phase 21 country
- Gut Microbiota-Based Clinical Study of Akkermansia Supplementation for Overweight and ObesityNot yet recruitingNCT07898267Not applicable1 country
- Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 DiabetesRecruitingNCT07866066Phase 32 countries
- Study of UBT37034 InjectionRecruitingNCT07873645Phase 11 country
- A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)RecruitingNCT07919678Phase 32 countries
- A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or ObesityRecruitingNCT07843498Phase 31 country
- A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related ComorbiditiesRecruitingNCT06672939Phase 36 countries
- Stearic Acid and Endothelial FunctionNot yet recruitingNCT07831603Not applicable1 country
- A Study of LY4247147 in Participants With Obesity or Overweight Who Are Otherwise HealthyNot yet recruitingNCT07915245Phase 12 countries
- A Study of Zovaglutide (ZT002 Injection) in Participants With Hepatic Impairment and Healthy ParticipantsNot yet recruitingNCT07916194Phase 11 country